Hypertriglyceridaemia-Induced Acute Pancreatitis: A Different Disease Phenotype

Greta Dancu1, Felix Bende1, Mirela Danila1

  • 1Center for Advanced Research in Gastroenterology and Hepatology, Department of Internal Medicine II, Division of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

Insights

Severe hypertriglyceridaemia-induced acute pancreatitis (HTGAP) presents a higher complication rate than other causes. Blood urea nitrogen (BUN) and hematocrit (HT) at 48 hours are key predictors of severity in HTGAP patients.

Area of Science:

  • Gastroenterology and Hepatology
  • Internal Medicine
  • Biomarker Discovery

Background:

  • Acute pancreatitis (AP) is a leading cause of hospitalization.
  • Severe hypertriglyceridaemia (HTG) is a significant, yet less common, etiology of AP (HTGAP).
  • HTGAP is suspected to have higher complication and severity rates compared to non-HTGAP.

Purpose of the Study:

  • To compare complication rates between HTGAP and non-HTGAP.
  • To identify predictive biomarkers for severe AP in HTGAP patients.

Main Methods:

  • Retrospective study of 262 AP patients.
  • Patients categorized into HTGAP (11%) and non-HTGAP groups.
  • Analysis of demographic data, comorbidities (diabetes mellitus), disease severity, complications, biomarkers (CRP, hematocrit, BUN), hospital stay, and mortality.

Main Results:

  • HTGAP patients were younger (44.4 vs. 58.2 years) and had higher rates of diabetes mellitus (53% vs. 18%).
  • HTGAP showed a more severe inflammatory response (higher CRP at 48h) and a trend towards more local complications.
  • Hematocrit (HT) and blood urea nitrogen (BUN) at 48 hours demonstrated high predictive value (AUC > 0.8) for severe AP; BUN at 48h was an independent predictor.

Conclusions:

  • HTGAP is associated with a more severe inflammatory profile and potentially higher rates of local complications compared to non-HTGAP.
  • BUN and hematocrit levels at 48 hours post-admission are valuable predictive markers for severe AP in the context of HTG.
  • Further research is warranted to elucidate the specific mechanisms driving HTGAP severity and to optimize management strategies.

Related Concept Videos

Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
521
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
184
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
187
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
651
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K